Shenzhen Hepalink Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,101
5,331
5,225
5,260
3,784
2,467
Total Accounts Receivable
356
481
581
723
1,218
1,377
Inventories
677
884
570
585
857
1,530
Other Current Assets
46
56
98
135
271
226
Total Current Assets
7,180
6,751
6,474
6,703
6,130
5,600
Net Property, Plant & Equipment
546
912
1,136
1,258
1,648
2,392
Total Investments and Advances
256
604
1,377
1,485
2,083
2,072
Long-Term Note Receivable
-
-
-
-
3
8
Intangible Assets
191
1,486
2,898
3,048
2,843
3,062
Other Assets
96
119
118
223
342
313
Total Assets
8,273
9,935
12,174
12,914
13,189
13,655
ST Debt & Current Portion LT Debt
-
4
657
1,783
2,889
Accounts Payable
73
98
99
71
139
Income Tax Payable
25
15
40
22
12
Other Current Liabilities
36
74
131
190
210
Total Current Liabilities
134
191
926
2,066
3,251
Long-Term Debt
-
1,005
1,785
2,095
1,829
Provision for Risks & Charges
-
41
45
58
77
Deferred Taxes
34
207
372
352
175
Other Liabilities
-
39
53
31
-
Total Liabilities
171
1,547
3,354
4,798
5,473
Common Equity (Total)
7,986
8,270
8,719
7,971
7,580
Total Shareholders' Equity
7,986
8,270
8,719
7,971
7,580
Total Equity
8,068
8,353
8,793
8,089
7,687
Liabilities & Shareholders' Equity
8,273
9,935
12,174
12,914
13,189
Accumulated Minority Interest
82
83
74
117
106
Non-Equity Reserves
34
36
28
27
30
About Shenzhen Hepalink Pharmaceutical Co.
View Profile
